Physician profile

Ranjitha Krishna

Periodontics · Marietta, GA

NPI 1912157355

$2,745.23

in general payments reported to CMS, 2019-2025

12 companies · $382 in 2025

The $382 reported for 2025 was more than what 78% of Periodontics providers received nationally (typical 2025 total: $111).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Gift$382.00
Food and Beverage$278.96
Entertainment$110.80
Education$100.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Straumann USA LLC $937.52 2019-2025
A-Dec, INC. $719.57 2023-2025
Biolase, INC. $467.13 2022
Midmark Corporation $274.12 2019
Biohorizons Implant Systems INC. $98.30 2019-2022
Carestream Dental, LLC $80.98 2019
Septodont INC. $72.93 2020
Thommen Medical USA, LLC $46.06 2021
Zimmer Biomet Holdings, INC. $13.06 2019
Philips North America LLC $12.78 2021
Nobel Biocare USA $11.78 2020
Orapharma, A Division of Bausch Health US, LLC $11.00 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ranjitha Krishna

$2,745.23

in general payments reported 2019-2025

Years
2019-2025
Top company
Straumann USA LLC
Context
The $382 reported for 2025 was more than what 78% of Periodontics providers received nationally (typical 2025 total: $111).

https://glasscript.com/doctor/531669/ranjitha-krishna

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.